ALNY P/B: current value, 10-year range and year-by-year history
Cash & Leverage
ALNY's p/b is higher than 65% of the last 10 years.
P/B History
ALNY P/B by year
Yearly range of ALNY’s p/b from 2016 to 2026. Over the full period it ranged from -11,859.9 to 1,194.5, averaging -223.5.
| Year | Low | Average | High | Year-end |
|---|---|---|---|---|
| 2026 | 21.0 | 42.0 | 73.0 | 25.3 |
| 2025 | 68.7 | 313.6 | 557.2 | 68.7 |
| 2024 | -11,859.9 | -2,465.1 | 1,194.5 | 451.0 |
| 2023 | -183.5 | -112.5 | -52.2 | -151.6 |
| 2022 | -435.8 | -46.8 | 160.6 | -429.2 |
| 2021 | 14.5 | 22.9 | 34.5 | 34.5 |
| 2020 | 7.2 | 11.2 | 14.9 | 14.9 |
| 2019 | 4.4 | 5.8 | 8.9 | 8.9 |
| 2018 | 4.3 | 6.0 | 8.1 | 5.7 |
| 2017 | 3.4 | 7.1 | 12.1 | 11.0 |
| 2016 | 2.7 | 4.0 | 6.1 | 3.2 |
Get notified when ALNY P/B crosses a threshold
Free — one alert setup, notifications by push, Telegram, or Discord.
How much the market pays relative to the company's accounting net worth (assets minus liabilities). P/B < 1 means the market values the company below what the books say it owns.
Price / Book Value Per ShareMost useful for asset-heavy businesses: banks, insurers, REITs. A P/B near its historical low suggests the market is paying unusually little for the net assets.
- Goodwill and intangibles from acquisitions can inflate book value significantly — some analysts prefer tangible book value.
- Low P/B in technology or software companies is usually irrelevant: their value is in IP and people, not balance sheet assets.
Is ALNY P/B High or Low Right Now?
Alnylam Pharmaceuticals, Inc.'s P/B is currently 25.3, which is above average relative to its 10-year historical range. The 10-year median P/B for ALNY is approximately 8.7. See all ALNY valuation metrics →
Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.